Transgene (France) Top Management

Transgene Management Team Effectiveness

The company has return on total asset (ROA) of (0.4935) % which means that it has lost $0.4935 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.2048) %, meaning that it generated substantial loss on money invested by shareholders. Transgene's management efficiency ratios could be used to measure how well Transgene manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.69. The current year's Return On Capital Employed is expected to grow to -1.38. At present, Transgene's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 7.7 M, whereas Total Assets are forecasted to decline to about 46.1 M. The current year's Common Stock Shares Outstanding is expected to grow to about 140.9 M, whereas Net Loss is forecasted to decline to (39.6 M). Transgene SA shows a total of 273.91 Million outstanding shares. Transgene SA maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Transgene in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Transgene, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Transgene Workforce Comparison

Transgene SA Benchmark Summation

Transgene Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Transgene SA often depends on how effective the management is. Transgene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Transgene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Transgene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Transgene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Transgene's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Transgene's management manipulating its earnings.

When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.